Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Science Track

Prognostic value of pre-treatment 18F-FDG PET/CT volumetric parameters in patients with locally advanced larynx carcinoma.

Gaetano Paone, Mariana Raditchkova-Sarnelli, Luca Ceriani and Luca Giovanella
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 2716a;
Gaetano Paone
2Oncology Institute of Southern Switzerland Lugano Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariana Raditchkova-Sarnelli
2Oncology Institute of Southern Switzerland Lugano Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luca Ceriani
2Oncology Institute of Southern Switzerland Lugano Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luca Giovanella
1IOSI Bellinzona Bellinzona Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

2716a

Objectives the aim of this study was to assess the prognostic value of volumetric parameters measured on staging 18F-FDG PET/CT determining event free survival (EFS) and overall survival (OS) in patients with locally advanced larynx carcinoma treated with concurrent chemo-radiotherapy.

Methods we retrospectively analyzed 31 patients who performed a staging PET/CT for larynx carcinoma between 2008 and 2011. All patients had stage III-IV squamous cell carcinoma of the larynx treated with IMRT and concurrent chemotherapy. MTV, SUV max/mean and TLG were recorded. Univariate and multivariate analyses in association with Kaplan-Meier method were used to evaluate the prognostic value of these parameters considering EFS and OS.

Results In the univariate analysis, MTV (>20cm3) using a 2,5 SUV threshold had the best prognostic value than other PET/CT parameters. We found a significant difference for predicting EFS (p<0,0001) and OS (p>0,0001) between the high MTV 2.5 (>20 cm3) and low MTV 2.5 (&#8804; 20cm3). In multivariate analysis, MTV and visual interpretation of local invasion remained significantly associated with EFS and OS (p= 0.012) while SUV max and TLG became non-significant (p=0.4 for EFS and p=0.7 for OS). At median follow up of 40 months the relapse rate was 42% (13/31 pts)

Conclusions Our data suggest that the pre-treatment 18F-FDG PET/CT MTV (>20cm3) provide better prognostic information in patients with locally advanced larynx cancer than other PET/CT parameters. A 58% cure rate in this high risk population is encouraging and confirm that chemoradiation may be a therapeutic option.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic value of pre-treatment 18F-FDG PET/CT volumetric parameters in patients with locally advanced larynx carcinoma.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Prognostic value of pre-treatment 18F-FDG PET/CT volumetric parameters in patients with locally advanced larynx carcinoma.
Gaetano Paone, Mariana Raditchkova-Sarnelli, Luca Ceriani, Luca Giovanella
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 2716a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Prognostic value of pre-treatment 18F-FDG PET/CT volumetric parameters in patients with locally advanced larynx carcinoma.
Gaetano Paone, Mariana Raditchkova-Sarnelli, Luca Ceriani, Luca Giovanella
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 2716a;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Science Track

  • Usefulness of the total lesion glycolysis (TLG) ratio in predicting the therapeutic effect of head and neck cancer-A novel parameter-
  • Early response monitoring with 18F-FDG PET/CT after Chemoradiotherapy with Cetuximab in head and neck Squamous Cell Carcinoma Patients (HNSCC)
  • Clinical management and outcomes in differentiated thyroid cancer patients with positive postoperative-stimulated thyroglobulin antibody and undetectable postoperative-stimulated thyroglobulin at initial 131I ablation after total thyroidectomy
Show more Oncology, Clinical Science Track

MTA I: Head and Neck Posters

  • Clinical value of 68Ga-DOTATATE PET/CT in the evaluation of recurrent medullary thyroid cancer patients.
  • The diagnostic performance and added value of 18F-NaF PET/CT in the detection of bone metastases in patients with nasopharyngeal carcinoma
Show more MTA I: Head and Neck Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire